Literature DB >> 29713816

Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy.

Osamu Sawada1, Yusuke Ichiyama2, Syunpei Obata2, Yuka Ito2, Masashi Kakinoki2, Tomoko Sawada2, Yoshitsugu Saishin2, Masahito Ohji2.   

Abstract

PURPOSE: To compare the ability of wide-angle optical coherence tomography angiography (OCTA) with that of ultra-wide field fluorescein angiography (UWFFA) to detect non-perfusion areas (NPAs) or retinal neovascularization (NV) in eyes with diabetic retinopathy (DR).
METHODS: Patients with DR underwent UWFFA using the Optos® panoramic 200Tx imaging system and wide-angle OCTA with 12 × 12 mm fields of five visual fixations using the PLEX Elite 9000®. We compared the abilities of UWFFA and OCTA to detect NPAs and NV.
RESULTS: Fifty-eight eyes of 33 patients (mean age, 60.0 years old; female/male, 16/17) with DR were evaluated. NPAs were detected in 47 out of 58 eyes using UWFFA and in 48 eyes using OCTA. NVs were detected in 25 out of the 58 eyes using UWFFA and in 26 eyes using OCTA. The sensitivity for detection of NPA using OCTA was 0.98, and the specificity was 0.82. The sensitivity for detection of NV was 1.0, and the specificity was 0.97.
CONCLUSION: The wide-angle OCTA seems to be clinically useful for the detection of NPAs or NV.

Entities:  

Keywords:  Diabetic retinopathy; Fluorescein angiography; Non-perfusion area; Ocular coherence tomography angiography; Retinal neovascularization

Mesh:

Year:  2018        PMID: 29713816     DOI: 10.1007/s00417-018-3992-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

Review 1.  Diabetic retinopathy.

Authors:  David A Antonetti; Ronald Klein; Thomas W Gardner
Journal:  N Engl J Med       Date:  2012-03-29       Impact factor: 91.245

2.  Select Features of Diabetic Retinopathy on Swept-Source Optical Coherence Tomographic Angiography Compared With Fluorescein Angiography and Normal Eyes.

Authors:  David A Salz; Talisa E de Carlo; Mehreen Adhi; Eric Moult; WhooJhon Choi; Caroline R Baumal; Andre J Witkin; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

3.  Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography.

Authors:  Richard F Spaide
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

4.  Optical Coherence Tomography Angiography of Diabetic Retinopathy in Human Subjects.

Authors:  Douglas R Matsunaga; Jack J Yi; Lisa Olmos De Koo; Hossein Ameri; Carmen A Puliafito; Amir H Kashani
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2015-09       Impact factor: 1.300

5.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

6.  Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Harumasa Yokota; Atsushi Takahashi; Tsuneaki Omae; Young-Seok Song; Tatsuhisa Takahashi; Akitoshi Yoshida
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

7.  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

8.  Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy.

Authors:  Matthew M Wessel; Grant D Aaker; George Parlitsis; Minhee Cho; Donald J D'Amico; Szilárd Kiss
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

Review 9.  Fluorescein angiography complication survey.

Authors:  L A Yannuzzi; K T Rohrer; L J Tindel; R S Sobel; M A Costanza; W Shields; E Zang
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

10.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY.

Authors:  Thomas S Hwang; Yali Jia; Simon S Gao; Steven T Bailey; Andreas K Lauer; Christina J Flaxel; David J Wilson; David Huang
Journal:  Retina       Date:  2015-11       Impact factor: 4.256

  10 in total
  32 in total

1.  Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.

Authors:  Gina Yu; Michael T Aaberg; Tapan P Patel; Rahul S Iyengar; Corey Powell; Annie Tran; Caitlin Miranda; Emma Young; Katarina Demetriou; Laxmi Devisetty; Yannis M Paulus
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

2.  Wide-field optical coherence tomography angiography for the detection of proliferative diabetic retinopathy.

Authors:  Francesco Pichi; Scott D Smith; Emad B Abboud; Piergiorgio Neri; Elizabeth Woodstock; Steven Hay; Emily Levine; Caroline R Baumal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-30       Impact factor: 3.117

3.  OCT angiography-based monitoring of neovascular regression on fibrovascular membrane after preoperative intravitreal conbercept injection.

Authors:  Zizhong Hu; Yun Su; Ping Xie; Lu Chen; Jiangdong Ji; Ting Feng; Shaowei Wu; Kang Liang; Qinghuai Liu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-05-03       Impact factor: 3.117

4.  The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.

Authors:  Fares Antaki; Razek Georges Coussa; Mikel Mikhail; Cyril Archambault; David E Lederer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-16       Impact factor: 3.117

5.  Retinal Nonperfusion Relationship to Arteries or Veins Observed on Widefield Optical Coherence Tomography Angiography in Diabetic Retinopathy.

Authors:  Akihiro Ishibazawa; Lucas R De Pretto; A Yasin Alibhai; Eric M Moult; Malvika Arya; Osama Sorour; Nihaal Mehta; Caroline R Baumal; Andre J Witkin; Akitoshi Yoshida; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

6.  Microvascular retinal changes in pre-clinical diabetic retinopathy as detected by optical coherence tomographic angiography.

Authors:  Jing Yan Yang; Qian Wang; Yan Ni Yan; Wen Jia Zhou; Ya Xing Wang; Shou Ling Wu; Ming Xia Yuan; Wen Bin Wei; Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-02       Impact factor: 3.117

7.  Correlation between the Nonperfusion Area on Ultra-Widefield Fluorescein Angiography and Nonflow Area on Optical Coherence Tomographic Angiography in Retinal Vein Occlusion.

Authors:  Jianfeng Huang; Yingyi Lu; Xiaoya Gu; Bodi Zheng; Tong Chen
Journal:  J Ophthalmol       Date:  2021-04-30       Impact factor: 1.909

Review 8.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

9.  DETECTION OF CLINICALLY UNSUSPECTED RETINAL NEOVASCULARIZATION WITH WIDE-FIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  Qi Sheng You; Yukun Guo; Jie Wang; Xiang Wei; Acner Camino; Pengxiao Zang; Christina J Flaxel; Steven T Bailey; David Huang; Yali Jia; Thomas S Hwang
Journal:  Retina       Date:  2020-05       Impact factor: 3.975

10.  Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study.

Authors:  Christof Haensli; Katrin Fasler; Daniel Barthelmes; Sandrine A Zweifel
Journal:  J Ophthalmol       Date:  2021-07-14       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.